Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Therapeutic Innovation & Regulatory Science
|
February 24, 2018
Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
Mitchell Klopfenstein, Luann E Van Campen, Timothy Garnett
Current Medical Research and Opinion
|
March 31, 2010
Developing good scientific publishing practices: one pharmaceutical company's perspective
Sherie A Dowsett, Luann E Van Campen, Lisa A Bednar
BMC Medical Ethics
|
March 26, 2021
Considerations for applying bioethics norms to a biopharmaceutical industry setting
Luann E Van Campen, Tatjana Poplazarova, Donald G Therasse, et al.
Current Medical Research and Opinion
|
September 2, 2015
Eli Lilly and Company's bioethics framework for human biomedical research
Luann E Van Campen, Donald G Therasse, Mitchell Klopfenstein, et al.
Current Medical Research and Opinion
|
September 2, 2015
Development, implementation and critique of a bioethics framework for pharmaceutical sponsors of human biomedical research
Luann E Van Campen, Donald G Therasse, Mitchell Klopfenstein, et al.
AJOB Empirical Bioethics
|
January 8, 2016
A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
Luann E Van Campen, Albert J Allen, Susan B Watson, et al.
Hearing Research
|
April 13, 2002
Oxidative DNA damage is associated with intense noise exposure in the rat
Luann E Van Campen, William J Murphy, John R Franks, et al.
Journal of Occupational and Environmental Hygiene
|
July 13, 2005
Ototoxic occupational exposures for a stock car racing team: II. chemical surveys
Kristin K Gwin, Kenneth M Wallingford, Thais C Morata, et al.
Journal of Occupational and Environmental Hygiene
|
August 6, 2005
Ototoxic occupational exposures for a stock car racing team: I. Noise surveys
Luann E Van Campen, Thais Morata, Chucri A Kardous, et al.
Bipolar Disorders
|
September 12, 2007
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression
Sanjay Dubé, Gary D Tollefson, Michael E Thase, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Therapeutic Innovation & Regulatory Science
|
February 24, 2018
Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
Mitchell Klopfenstein, Luann E Van Campen, Timothy Garnett
Current Medical Research and Opinion
|
March 31, 2010
Developing good scientific publishing practices: one pharmaceutical company's perspective
Sherie A Dowsett, Luann E Van Campen, Lisa A Bednar
BMC Medical Ethics
|
March 26, 2021
Considerations for applying bioethics norms to a biopharmaceutical industry setting
Luann E Van Campen, Tatjana Poplazarova, Donald G Therasse, et al.
Current Medical Research and Opinion
|
September 2, 2015
Eli Lilly and Company's bioethics framework for human biomedical research
Luann E Van Campen, Donald G Therasse, Mitchell Klopfenstein, et al.
Current Medical Research and Opinion
|
September 2, 2015
Development, implementation and critique of a bioethics framework for pharmaceutical sponsors of human biomedical research
Luann E Van Campen, Donald G Therasse, Mitchell Klopfenstein, et al.
AJOB Empirical Bioethics
|
January 8, 2016
A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
Luann E Van Campen, Albert J Allen, Susan B Watson, et al.
Hearing Research
|
April 13, 2002
Oxidative DNA damage is associated with intense noise exposure in the rat
Luann E Van Campen, William J Murphy, John R Franks, et al.
Journal of Occupational and Environmental Hygiene
|
July 13, 2005
Ototoxic occupational exposures for a stock car racing team: II. chemical surveys
Kristin K Gwin, Kenneth M Wallingford, Thais C Morata, et al.
Journal of Occupational and Environmental Hygiene
|
August 6, 2005
Ototoxic occupational exposures for a stock car racing team: I. Noise surveys
Luann E Van Campen, Thais Morata, Chucri A Kardous, et al.
Bipolar Disorders
|
September 12, 2007
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression
Sanjay Dubé, Gary D Tollefson, Michael E Thase, et al.
Page
of 2